LIPO (Lipella Pharmaceuticals) Valuation Rank


LIPO Lipella Pharmaceuticals Inc LIPO
35 GF Score
Price $0.13
GF Value $8.69
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Lipella Pharmaceuticals Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Lipella Pharmaceuticals Valuation Rank Related Terms

LIPO
35GF Score
Lipella Pharmaceuticals Inc LIPO
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lipella Pharmaceuticals (LIPO) Overvalued in 2026?

Based on GuruFocus' analysis, Lipella Pharmaceuticals stock appears to be undervalued. The current stock price of $0.13 is trading 98.5% below its estimated GF Value™ of $8.69. GuruFocus considers Lipella Pharmaceuticals to be Possible Value Trap.

Key valuation signals for LIPO:

  • Valuation Rank:
  • GF Value™: $8.69 vs. price of $0.13 (98.5% below fair value)
  • GF Score™: 35/100 with 1 warning sign

No single metric tells the full story. See the LIPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
35GF Score

Get the complete analysis for LIPO

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price
$8.69
GF Value